Multidisciplinary Day-Clinic Treatment for Functional Movement Disorders Embedded in a Movement Disorders Center
Objective: To evaluate the feasibility and effectiveness of a multimodal day-clinic treatment program for patients with functional movement disorders (FMD) integrated into a neurological movement…Clinical feasibility of a semi-automated Olfactometry System in α-Synucleinopathies
Objective: To evaluate the feasibility, performance, and diagnostic accuracy of a semi-automated olfactometry system (NOS-DX1000) for standardized assessment of olfactory dysfunction in α-synucleinopathies. Background: Olfactory…Exploring Demographic Correlates of Diagnostic Interval of Parkinson’s Disease
Objective: This study aims to evaluate demographic correlates of time to diagnosis among adults with Parkinson’s disease in Texas. Background: Parkinson’s disease (PD) is a…Cognitive & Clinical Correlates of Quality of Life in Probable Progressive Supranuclear Palsy
Objective: To examine the relationship between cognitive, executive, motor & autonomic function, neuropsychiatric symptoms, and health-related quality of life (HRQoL) in patients with progressive supranuclear…A Phase 1b Study to Investigate Safety, Tolerability and Biomarker Responses of Repeated Subcutaneous Doses of HER-096 in Subjects with Parkinson’s Disease
Objective: The aim of this study was to investigate safety, tolerability and biomarker responses of repeated subcutaneous (s.c.) doses of HER-096 in subjects with Parkinson’s…Digital acoustic biomarkers of botulinum toxin response in laryngeal dystonia: a longitudinal case report
Objective: To assess whether longitudinal acoustic analysis can objectively capture treatment response to botulinum toxin type a (BoNT-A) in laryngeal dystonia. Background: Objective longitudinal markers…EEG-based Functional Connectivity Reveals a Genotype-Specific Network Signature in GBA-Associated Parkinson’s Disease
Objective: to investigate whether PD patients carrying pathogenetic GBA variants exhibit distinct frequency-specific EEG-based FC alterations compared with GBA1-negative PD patients (PD-GBA−). Background: Variants in the GBA1 gene…Optimizing Identification of Hyposmia for Parkinson’s Disease Risk Screening: Results from the Healthy Brain Aging Study
Objective: To evaluate whether questionnaire-based variables can identify individuals with Olfactory Dysfunction (OD), thereby supporting a targeted preselection approach for Parkinson’s Disease (PD) screening. Background:…Sex Differences in Disease Severity and Impact for Progressive Supranuclear Palsy and Corticobasal Syndrome
Objective: Assess sex differences in disease severity, quality of life (QOL) and caregiver burden in early- and late-onset progressive supranuclear palsy (PSP) and corticobasal syndrome…Age-Related Hearing Loss in Idiopathic Parkinson’s Disease and APOE E4 Carriers
Objective: Identify whether APOE E4 modulates the relationship between age and hearing loss in idiopathic Parkinson’s disease (PD). Background: Hearing loss is associated with increased…
- « Previous Page
- 1
- …
- 131
- 132
- 133
- 134
- 135
- …
- 208
- Next Page »